Dross
12-27-2007, 10:46 AM
A new story entry has been added:
Treating oft ignored non-cancer health issues after cancer diagnosis prolongs survival
INDIANAPOLIS ?Receiving treatment for non-cancer health issues while being treated by specialists for cancer improves cancer survival rates according to a study published in the December 20 issue of the Journal of Clinical Oncology.
The study, by researchers from the Indiana University School of Medicine, the Regenstrief Institute and the Roudebush Veterans Administration Medical Center, is the first to look at the effect of primary care on health outcomes in cancer patients.
Receiving care from a primary care physician (a general internist or family practice doctor) during cancer treatment from an oncologist appears to improve cancer survival rates, likely due to the comprehensiveness of care that is received in primary care, according to study authors Caroline Carney Doebbeling, M.D., M.Sc. and Laura Jones, Ph.D. The researchers focused on lung cancer because of the low one-year lung cancer survival rate in these patients.
Treating oft ignored non-cancer health issues after cancer diagnosis prolongs survival
INDIANAPOLIS ?Receiving treatment for non-cancer health issues while being treated by specialists for cancer improves cancer survival rates according to a study published in the December 20 issue of the Journal of Clinical Oncology.
The study, by researchers from the Indiana University School of Medicine, the Regenstrief Institute and the Roudebush Veterans Administration Medical Center, is the first to look at the effect of primary care on health outcomes in cancer patients.
Receiving care from a primary care physician (a general internist or family practice doctor) during cancer treatment from an oncologist appears to improve cancer survival rates, likely due to the comprehensiveness of care that is received in primary care, according to study authors Caroline Carney Doebbeling, M.D., M.Sc. and Laura Jones, Ph.D. The researchers focused on lung cancer because of the low one-year lung cancer survival rate in these patients.